trimetazidine has been researched along with Peripheral Arterial Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, T; Shao, S; Xu, Q; Yang, Y | 1 |
| Banach, M; Chrusciel, P; Rysz, J | 1 |
| Bonassi, S; Cerquetani, E; Dall'Armi, V; Fini, M; Marazzi, G; Mercuro, G; Pelliccia, F; Rosano, GM; Spoletini, I; Vitale, C; Volterrani, M | 1 |
1 review(s) available for trimetazidine and Peripheral Arterial Disease
| Article | Year |
|---|---|
Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.
Topics: Cardiovascular Agents; Cardiovascular Diseases; Heart Failure; Humans; Peripheral Arterial Disease; Trimetazidine | 2014 |
1 trial(s) available for trimetazidine and Peripheral Arterial Disease
| Article | Year |
|---|---|
Trimetazidine improves exercise performance in patients with peripheral arterial disease.
Topics: Aged; Ankle Brachial Index; Exercise; Exercise Test; Female; Humans; Male; Middle Aged; Peripheral Arterial Disease; Trimetazidine; Vasodilator Agents | 2011 |
1 other study(ies) available for trimetazidine and Peripheral Arterial Disease
| Article | Year |
|---|---|
Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Hindlimb; Humans; Intercellular Adhesion Molecule-1; Ischemia; Lower Extremity; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Peripheral Arterial Disease; Trimetazidine; Vascular Endothelial Growth Factor A | 2021 |